Biblio
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial. Lancet Oncol. 2023;24(7):811-822.
Risk Factors for Development of Pneumatosis Intestinalis After Pediatric Hematopoietic Stem Cell Transplantation: A Single-Center Case-Control Study. Transplant Cell Ther. 2022.
Revisiting the utility of G-CSF post-autologous hematopoietic stem cell transplantation for outpatient-based transplants. Transplant Cell Ther. 2023.
. Race and Survival in Unrelated Hematopoietic-cell Transplantation. Transplant Cell Ther. 2022.
. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IIb. The 2020 Preemptive Therapy Working Group Report. Transplant Cell Ther. 2021.
The Impact of Body Mass Index on the Outcome of Hematopoietic Stem Cell Transplantation in Adults. Biol Blood Marrow Transplant. 2018.
. Fatigue in Hematopoietic Cell Transplant Survivors: Correlates, Care Team Communication, and Patient-Identified Mitigation Strategies. Transplant Cell Ther. 2022.
Cryopreservation of Growth Factor-Mobilized Peripheral Blood Stem Cells Does Not Compromise Major Outcomes after Allogeneic Hematopoietic Cell Transplantation - A Single Center Experience. Transplant Cell Ther. 2023.
. Azithromycin use and increased cancer risk among patients with bronchiolitis obliterans after hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2019.